STAT3 and depressive disorder: This study provides integrative In-silico and In-vitro evidence that Duloxetine, an SNRI widely used to treat depressive disorder and for chronic pain, exerts a pleiotropic mechanism of action by directly targeting phosphorylated STAT3 (pSTAT3) signaling in addition to its canonical role in neurotransmitter reuptake inhibition.